‘In silico’ repurposing new inhibitors of EGFR and VEGFR-2 kinases via biophysical mechanisms | Ibrahim Khater

‘In silico’ repurposing new inhibitors of EGFR and VEGFR-2 kinases via biophysical mechanisms

Citation:: Ibraheim, M. H., I. Maher, and I. Khater, "‘In silico’ repurposing new inhibitors of EGFR and VEGFR-2 kinases via biophysical mechanisms", JOURNAL OF BIOMOLECULAR STRUCTURE AND DYNAMICS, vol. 42, issue 18, pp. 9571-9586, 2023.